Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Pseudotumor Cerebri

Out of Stock

Price data checked 1 day ago

View at Amazon

One email. No newsletter. No nudges.

Sold out. We send one email the moment it's back. Last time, that took just a day or two.

Out of stock 1 day

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
09 April 2024

Similar Products You Might Like

The 2023-2028 World Outlook for Pseudotumor Cerebri
99% match

The 2023-2028 World Outlook for Pseudotumor Cerebri

Out of Stock 09 Jan 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in the United States
99% match

The 2023-2028 Outlook for Pseudotumor Cerebri in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in China
99% match

The 2023-2028 Outlook for Pseudotumor Cerebri in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in Japan
99% match

The 2023-2028 Outlook for Pseudotumor Cerebri in Japan

£495.00 10 Jun 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in India
98% match

The 2023-2028 Outlook for Pseudotumor Cerebri in India

£515.00 31 Jan 2026
The 2023-2028 Outlook for Pseudotumor Cerebri for US Zip Codes
98% match

The 2023-2028 Outlook for Pseudotumor Cerebri for US Zip Codes

£490.00 28 Jan 2026
The 2025-2030 World Outlook for Primary Brain Tumor Diagnosis and Treatments
96% match

The 2025-2030 World Outlook for Primary Brain Tumor Diagnosis and Treatments

Out of Stock 10 Jan 2026
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments
96% match

The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 11 Jan 2026
The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments
96% match

The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 06 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States
96% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States

£520.00 10 Jan 2026
The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitoring Devices
96% match

The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitoring Devices

Out of Stock 24 May 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
96% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 12 Mar 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India
95% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India

£515.00 10 Jun 2026
The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitors
95% match

The 2021-2026 World Outlook for Intracranial Pressure (ICP) Monitors

£795.00 22 May 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan
95% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments for US Zip Codes
95% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments for US Zip Codes

£490.00 24 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
95% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India

£515.00 24 Feb 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan
95% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan

£495.00 10 Jun 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China
95% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China

£495.00 09 Jan 2026
The 2025-2030 World Outlook for Vision Process Units
95% match

The 2025-2030 World Outlook for Vision Process Units

Out of Stock 22 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India
95% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India

£515.00 06 Feb 2026